Therefore, the aim of the present study was to investigate the plasma levels of BMP9, BMP10 and sEng in a well-characterised cohort of patients with liver disease to assess whether the levels of these ligands change and if they segregate with disease severity or pulmonary vascular complications. Here, GDF2 is linked to liver disorder.